Aida Zarfeshani

Feinstein Institute for Medical Research

Also affiliated with SignPath Pharma (United States), Menlo School

Immunology and MicrobiologyMedicineNeuroscienceBiochemistry, Genetics and Molecular BiologyAgricultural and Biological Sciences

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “Cognitive Impairment in SLE: Mechanisms and Therapeutic Approaches”.

Cognitive Impairment in SLE: Mechanisms and Therapeutic Approaches

Current Rheumatology Reports(2021)10.1007/s11926-021-00992-1

N/A

0DataRank · unranked

18 citations

Kaitlin R. Carroll, Bruce T. Volpe, Betty Diamond, Aida Zarfeshani

Lupus autoantibodies initiate a maladaptive equilibrium sustained by HMGB1:RAGE signaling and reversed by LAIR-1:C1q signaling

bioRxiv (Cold Spring Harbor Laboratory)(2023)10.1101/2023.05.01.538935

N/A

0DataRank · unranked

1 citations

Mark Mizrachi, Sean K. Simmons, Bahtiyar Toz, Jeffrey Wingard, Nazila Tehrani +7 more

Lupus autoantibodies initiate neuroinflammation sustained by continuous HMGB1:RAGE signaling and reversed by increased LAIR-1 expression

Nature Immunology(2024)10.1038/s41590-024-01772-6

N/A

0DataRank · unranked

35 citations

Mark Mizrachi, Sean K. Simmons, Bahtiyar Toz, Czeslawa Kowal, Jeffrey Wingard +9 more